Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib for Inflammatory Eye Disease
NCT03580343Phase 2Unknown
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2019
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
A Phase 2 trial of tofacitinib oral solution in uveitis, scleritis, sponsored by Washington University School of Medicine. Status: unknown.
02
Drugs
tofacitinib oral solution
03
Conditions
uveitisscleritis
Beyond the preview
Go deeper on NCT03580343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03580343.